Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
about
Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7The emerging roles of human tissue kallikreins in cancerThree dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.Gene network analyses point to the importance of human tissue kallikreins in melanoma progressionGenomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.Prognostic significance of multiple kallikreins in high-grade astrocytoma.The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Early detection biomarkers for ovarian cancer.Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinomaDifferential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous systemNew insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.Correlation of the expression of human kallikrein-related peptidases 4 and 7 with the prognosis in oral squamous cell carcinoma.KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.Polymorphisms in Kallikrein7 and 10 genes and oral cancer risks in Taiwan betel quid chewers and smokers.The role of human tissue kallikreins 7 and 8 in intracranial malignancies.Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry
P2860
Q24674282-CD84E362-35CD-466D-A442-A885A7934CB5Q28290701-6A2F1190-7767-4362-940D-46C3855C5EF1Q33794911-5BBB1EF8-34F3-4E71-AD50-058753A95D97Q34060071-4F238EE0-D5C5-42FC-9FFD-7529731554E0Q35032994-424B098F-6B95-4252-B2DD-B24C519FBC46Q35732225-E9A65513-1DD4-4CC5-9411-CE9C086D19AAQ35861497-9611E638-7FE4-4A9F-ACA0-16F53C193CACQ36520143-DA143149-572C-4BDF-80DE-379777D5B9EAQ36922664-87C9251D-CABE-481F-9BDC-A270CE1B58B8Q37154456-5BECFE5B-27D9-4BBF-A030-4E2CAFEF151CQ37453804-6155DBC7-55EB-4193-9112-EF0AC4295FCCQ37690308-48BE0037-D0D8-49B8-9E0C-354F8D738924Q38415467-79E85737-8822-4A29-8303-0AFFD6164C5AQ38718409-707EEB2C-18D1-46A2-B93F-2108CD975178Q39080408-5C6AA597-B607-479D-8281-86E8FF9888D1Q40262739-D8E642B1-856C-46D6-A2B4-F0F7D163374BQ44560386-201E3E88-0B97-4655-A6FA-5D3FB1DDBB5BQ48355523-FAD51B84-0CC6-48EA-BD89-55C1110D5583Q57940871-51C0E90A-9C85-4165-809E-52327AF96F7B
P2860
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
description
im März 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2003
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2003
@uk
name
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
@en
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
@nl
type
label
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
@en
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
@nl
prefLabel
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
@en
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
@nl
P2093
P1476
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
@en
P2093
Dionyssios Katsaros
George M Yousef
Lianna G Kyriakopoulou
Marco Massobrio
Stefano Fracchioli
P304
P356
10.1016/S0009-9120(02)00446-0
P577
2003-03-01T00:00:00Z